F Saad
Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer
Pezaro C, James N, Logothetis C, Morgans A, Parker C, Ryan C, Saad F, Sartor O, Small E, Sternberg C, Sweeney C, Tannock I, Tombal B, Hussain M, Higano C, Omlin A, Mastris K, Attard G, Beer T, Chi K, Chowdhury S, Davis I, Drake C, de Bono J, Efstathiou E, Gravis G, Gillessen Sommer S. Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer. Ann Oncol 2017; 28:1692-1694.
Aug 1, 2017Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer
Aug 1, 2017Ann Oncol 2017; 28:1692-1694
Pezaro C J, James N, Logothetis C J, Morgans A, Parker C, Ryan C J, Saad F, Sartor O, Small E J, Sternberg C N, Sweeney C J, Tannock I, Tombal B, Hussain M, Higano C S, Omlin Aurelius, Mastris K, Attard G, Beer T M, Chi K N, Chowdhury S, Davis I D, Drake C G, de Bono J S, Efstathiou E, Gravis G, Gillessen Sommer Silke
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Aapro M, Saad F, Rizzoli R, Paterson A, Monnier A, Lipton A, Jonat W, Hortobagyi G, Hadji P, Gralow J, Gnant M, Dirix L, Crinò L, Costa L, Colomer R, Coleman R, Body J, Abrahamsson P, Thürlimann B. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol 2008; 19:420-32.
Mar 1, 2008Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Mar 1, 2008Ann Oncol 2008; 19:420-32
Aapro M, Saad F, Rizzoli R, Paterson A H G, Monnier A, Lipton A, Jonat W, Hortobagyi G N, Hadji P, Gralow J, Gnant M, Dirix L, Crinò L, Costa L, Colomer R, Coleman R E, Body J J, Abrahamsson P A, Thürlimann Beat